General

Overview and Background
The "Systems Biology of Coagulation and Trauma-Induced Coagulopathy" project seeks to develop a comprehensive understanding of the fundamental, highly networked, molecular and physiological processes underlying normal coagulation and the perturbations of those processes that result in coagulopathy.
1A. General Overview
1A1. General Safety Issues and Precautions for Handling Blood Specimens
Laboratory safety protocols and procedures were followed In accordance with the Occupational Safety and Health Administration (OSHA) regulations on blood borne pathogens.
1A2. General Organization
All procedures performed are to be under IRB approved protocols and follow HIPPA regulations. General design of blood collection and processing is illustrated in the schematic below: *Note: The details in this manual refer to the assumption of one ROTEM (ROTEM delta) machine and one TEG (Haemonetics TEG-5000) machine being available; however, any combination of the machines may be used. The ROTEM consists of four channels and is capable of running four independent conditions; the Haemonetics TEG provides two channels and is also capable of running independent conditions. To obtain six channels, either 2x ROTEM, 1x ROTEM and 1x TEG, or 3x TEG will be required. The Haemonetics TEG assay and ROTEM assay can be used interchangeably, or side-by-side, for the protocols in this manual.
If TEG machines are used where ROTEM is specified in this manual, all volumes must be adjusted to account for the greater total cup volume (the TEG holds 360uL while the ROTEM holds 340uL). The activator volumes must be adjusted to maintain the concentrations present in the ROTEM, ex: 21.18uL of ExTEM and InTEM must be added to TEG channels to account for the greater volume. unique barcode or label. Aliquots are filled following a standard sequence noted both on a paper case report form (CRF).
2B. Phlebotomy Logistics
Phlebotomy will be performed by EMS personnel in the pre-hospital setting, and clinical RN or trained research staff in the other locations (ED or ICU). Ambulances are stocked with evacuated tubes and syringes in kits.
Research technicians are present for all draws after the patient's arrival to the hospital. The technicians will provide syringes to the nursing staff at the appropriate times and record draw information in the CRF, including:
1. Information on patient location (EMS, ED, or ICU) 2. Information on line used for blood collection (peripheral IV, central line, or arterial line) 3. Information on time variables (time from tube filling to centrifugation, aliquotting, and freezing) 4. Information on the quality of each tube sample collected
2C. Phlebotomy Details
Note: Attention should be paid to minimizing turbulence whenever possible. Small steps such as slanting the needle in the vacutainer to have the blood run down the side of the tube instead of shooting all the way to the bottom, may result in significant improvement in results.
1. The first draw off a patient's line at a given time point, should discard the first mL (for venipuncture) or 3 mL (for central line) using a 5 mL syringe. If other blood draws on the patient were already performed this step is not necessary. 2. Draw > 22 mL blood into a 20 mL syringe (the syringe has the capacity to overfill by a couple of mL). 3. Rapidly use the syringe to fill evacuated collection tubes. 4. If a direct venipuncture has been used instead of a central line, we recommend use of a butterfly assembly. Secure the needle in the arm and proceed to fill the tubes sequentially. For SCAT tubes (not sterile), attach a syringe (needle removed) to the butterfly line to fill the syringe then subsequently fill the SCAT tube. 5. All citrate and SCAT tubes are inverted 3-4 times then placed in a tube rack at room temperature (25°C) for transport to the laboratory. The PAXgene DNA tube must be inverted 8-10 times and similarly placed in a rack at room temperature for transport to the laboratory. 6. Immediately upon arrival to laboratory these tubes should be placed on a balance and their weights recorded on the CRF.
2D. Phlebotomy Master Schedule
The phlebotomy schedule lists time points for blood sample collection. Pretreatment blood, either from EMS or upon arrival to the ED, will be considered time 0 for the purposes of this study. It is essential to have pretreatment blood samples for inclusion in the study; all other samples will be obtained as feasible (e.g. patient care, disposition, or death may preclude complete sampling). 
Sample
2E. Phlebotomy Schedule for Thermal Injuries
Burn patients only will be followed for additional time-points after 24hrs, collected every 12hrs, for 7 days, and then day 14 and day 21 after admission. For each parameter, a score of "1" or "0" will be assigned. Criteria for each parameter is as follows: Only tubes that are centrifuged will be assigned a score for this parameter.
Sample
For each parameter that falls within the guidelines stated above, a score of "1" is assigned. Therefore, the "ideal" sample that fits all criteria listed above will receive a "3" (or a "2" if the tube is not centrifuged.) Each score will be noted on the CRF.
Number of good parameters Total score
All 3 parameters good (only for centrifuged tubes) 3 2 parameters good 2 1 parameter good 1 0 parameters good 0
3B. Transferring the Tubes from Collection Site to Processing
Transportation of blood samples to the laboratory for further processing and on-site TEG/ROTEM should be accomplished within 10 minutes. No more than 15 minutes should elapse between blood draw and processing. The tubes are to be transported at room temperature.
3C. Centrifugation for Plasma and Cell Sample Preparation (Citrate #1, #2, #3, #4, and SCAT)
Note: The purposes of centrifugation are: 1) to separate plasma from cells, including most of the platelets; 2) provide cellular material for preparation of DNA.
There are two options for centrifuging the tubes, choice A or choice B:
A) If possible, the SCAT tube should be subjected to a 'soft' spin, the plasma removed, and then the plasma subjected to a further 'hard' spin along with four of the citrate tubes. The cell pellet obtained from the SCAT tube 'soft' spin will undergo the Nucleic Acid Sample Preparation protocol in section 3E2 option A.
The procedure is as follows:
1. Centrifuge SCAT tube at room temp (25°C) at 400g for 10 min with brake OFF. Transfer plasma to a clean tube and: 2. Centrifuge citrate tubes #1, #2, #3, and #4 and the SCAT plasma from step 1 above (SCAT tube) at room temp (25°C), for 50,000 g-min (3,000g for 17 minutes) 3. Once centrifugation is complete, carefully remove tubes from centrifuge and place in tube rack. 4. Aliquot the plasma as described under section 3D and treat the SCAT tube cell pellet as described under section 3E2 option A. Freeze citrate tube cell pellets as described in section 3E2 option A.
B) If the on-site Nucleic Acid
Preparation is not feasible, perform only the 'hard' spin on all five tubes:
1. Centrifuge citrate tubes #1, #2, #3, and #4 and the SCAT tube at room temp (25°C), for 50,000 g-min (3,000g for 17 minutes) 2. Once centrifugation is complete, carefully remove tubes from centrifuge and place in tube rack. 3. Aliquot the plasma as described under section 3D and treat the pellet as described under section 3E2 option B.
3D. Aliquotting
Note: Proper labeling is critical on the cryovials into which the separated plasma is pipetted. Labels must be guaranteed to withstand freezing and thawing. Most standard office printers are not capable of printing in a permanent ink. Writing directly on the cryovials (i.e., not using a label) is not recommended. Aliquotting consists of removing the plasma in 0.5mL increments by pipette and placing it into the appropriate cryovials with color-coded O-ring caps for optimal seal.
1. Plasma from the SCAT and citrate tubes can be aliquotted directly from the draw tube.
2. This process is to be done with the tubes and cryovials at room temperature 3. Be careful not to disturb the top of the cell pellet with the pipette tip, as this will result in platelet, white cell and red cell contamination; try to avoid ~3 mm of sample from the very top of the cell layer as this contains the bulk of the platelets. 4. Use a new pipette tip for each draw tube type (citrate; SCAT). 5. Once the sample is aliquotted, cryovials should be frozen in an upright position immediately at -80°C. 6. There are separate instructions for continuing to process and store the separated cell pellets in section 3E.
3E. Nucleic Acid Sample Preparation (PAXgene tubes, Citrate #1, #2, #3, #4, and SCAT)
3E1. RNA Preservation from PAXgene RNA or Tempus Tubes
PAXgene RNA or Tempus tubes are used for RNA preservation. Upon draw the tube is inverted 8-10 times. The tube should immediately be placed into the -80°C freezer (no further handling).
3E2. DNA Preservation
If cell separations as described in 3C (option A) and 3E (below) are not possible at the site, and an additional tube can be accommodated based on total volume of draw:
PAXgene DNA tubes are used for DNA preservation and immediately upon draw the tube is inverted 8-10 times. The tube can be placed into the -80°C freezer (no further handling).
Alternatively:
After processing the plasma from the citrate and SCAT tubes as described in section 3C+D, the cell pellets that are remaining in the tubes are processed for DNA preservation. There are two options for processing these pellets:
Option A. For SCAT tube (whose pellet was only subject to a "soft" spin) perform red blood cell lysis prior to freezing, per protocol below. NOTE: This protocol is adapted from Dr. Brownstein, which required a blood draw involving a 7 mL EDTA tube. All reagents should be appropriately scaled down to reflect the actual draw volume. 
Reagents
3F. Local Sample Storage
All frozen samples should be stored frozen at -80°C until aliquots are processed or shipped to collaborating sites. Samples are preserved using screw-top storage tubes with barcodes and labels which are stable at -80°C.
TEG/ROTEM (Citrate #5)
4A. Assay and Instrument Principle
Measurements of the viscoelastic properties of clot formation and clot lysis in whole blood samples are obtained using either rotational thromboelastometry (ROTEM machine) or thromboelastography (Haemonetics TEG machine). This manual illustrates both ROTEM and TEG methods but any combination of machines may be used; when conducted under identical conditions by skilled technicians, and the output of these machines is equivalent.
4B. Assay Principle for Systems Biology Protocol
Blood will be drawn by hospital staff via either venipuncture or through a pre-established line at indicated time points. Blood will be immediately citrated to prevent clotting prior to assay time. When the assay is performed, the blood that has been collected into the citrate tube must now be recalcified to overcome the citrate, thus providing calcium essential to clotting, and in most cases will contain an activator to initiate clotting.
Each draw will consist of six experiments; they are summarized in the table below and described in detail in this section:
4D. Instrument Set Up
The ROTEM and TEG machines must be on for at least 15 min prior to assay time to allow the cuvette holders to reach 37°C. For the Systems Biology protocol, they should remain on at all times.
4D1. Assay Start
This protocol starts with the acquisition of blood drawn into a 2.7mL evacuated sodium citrate tube, as outlined in section 3A, yielding a final sodium citrate concentration of 10.88 mM. Complete a CRF for each assay.
4D2. TEG Experiments
Before each TEG assay, verify that the machine is level by inspecting the bubble-level on the top of the machine (see Figure below) . Also verify that both channels are at 37°C (temperature monitor if found on front of machine). Once all samples have been started, press "done" on the TEG screen to view curves and parameters as they are established.
Run the channels for 1.5 hours. Stop channels after 1.5 hours by pressing "stop" on the TEG screen for each channel. Eject the cups and pins by moving the lever to "load" and pressing downward (see previous figure) . Slide carrier down and press firmly past the first stop, ejecting the cup and pin; discard of cups and pins in biohazard waste.
4D3. ROTEM Experiments
1. The ROTEM instruments must be in "measurement" mode; the compatibility with automatic pipette use must be confirmed (can be adjusted in "setup" module) *When expelling fluid, be sure the tip is NOT in the fluid or at the level which it will fill to. After ejecting fluid, the pipette fires once more to ensure that all fluid is out of tip-if the tip is in the expelled fluid, it will draw some back up and the required volume will not have been ejected.
i. Start the pipetting sequence by selecting the right-hand channel and pressing "Start.
ii. Press the pipette firmly into a clean tip.
iii. Place the tip well into the appropriate reagent and press the central blue button on the pipette, then press the button for air cushion; next place the pipette tip into the activator and press the blue button one more time.
iv. Place the tip over the cup so that the fluid will be expelled into the bottom center of the cup. Do not touch the bottom of the cup. Press the blue button.
v. Eject tip (either side-button on the pipette) and replace with a new tip.
vi. Invert citrate tube of blood end-over-end three times and place pipette tip well into the blood (note: it is important that the tip is at least ½ way into the vial; 300uL will be pulled out, and the appropriate volume of blood will not be drawn if the pipette draws up any air). Press blue button. § No need to recap and invert blood between channels vii. Rest the pipette tip on the rim of the ROTEM cup so that the blood runs down the side of the cup when expelled. Do not place the tip far into the cup. Press the blue button.
viii. Without replacing the pipette tip, place the tip at the bottom edge of the cup and press the blue button to draw up all the fluid in the cup.
ix. Expel blood back into cup as before.
x. Using hand not holding the pipette, slide incubation chamber (containing the cup) up until it magnetically attaches to the machine unit. Press okay in the dialog box that has popped up (note: you have less than 30 seconds to slide the chamber up and hit okay before the entire run is terminated).
xi. Eject tip into biohazard waste container and use the touch-screen to move to the next channel.
xii. Repeat steps i-xi for each channel, using the appropriate reagents for that experimental channel xiii. Immediately clean up any drops or spills.
Run the channels for a total of 1.5 hours. Stop the channels after 1.5 hours by pressing "stop channel" for each channel (machines can be programmed to terminate after 1.5 hours automatically). Save the data by pressing "clear channel" for each channel. Lower the cup holders by firmly pressing the blue clip on the chamber (this will "grab" the pin) and lowering the unit. Pop the cup/pin out of the chamber by pressing it against the ejection post, and discard cups and pins in biohazard waste container.
Note: There may not be sufficient volume for all 6 channels, as care should be taken not to exceed the approved amount of blood for the draw (5 mL); the two TEG channels should be run first, followed by the ROTEM channels in the order they are described. If blood volume is not sufficient, the uninitiated sample should be omitted.
8. Run the ROTEM for 1.5 hours 9. Press "clear channel" for each of the ROTEM channels to save data 10. Remove cups and pins for holders and discard in biohazard trash
Shipping of Blood Samples to Collaborating Laboratories
5A. Shipping Protocol
These instructions pertain to frozen blood samples shipments between collaborating sites. Plan to ship samples on Monday or Tuesday via Fed Ex Priority overnight or Approved Courier.
